GlassScriptPhysician profile
Michael Andrew Ahdoot
NPI 1255775912
$24,623.97
in general payments reported to CMS, 2019-2025
20 companies · $18K in 2025
The $18K reported for 2025 was more than what 96% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $89.57 · 2021: $13.50 · 2022: $757 · 2023: $4,372 · 2024: $1,809 · 2025: $18K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $11K · Food and Beverage: $4,980 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,500 · Education: $1,659 · Travel and Lodging: $1,302 · Gift: $22.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $11,300.00 |
| Food and Beverage | $4,980.21 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,500.00 |
| Education | $1,658.52 |
| Travel and Lodging | $1,302.38 |
| Gift | $22.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edap Technomed INC | $9,186.27 | 2022-2025 | |
| Immunitybio, INC. | $4,837.40 | 2025 | |
| Ferring Pharmaceuticals INC. | $4,097.75 | 2025 | Adstiladrin |
| Intuitive Surgical, INC. | $3,633.47 | 2022-2023 | Da Vinci Surgical System, Da Vinci Sp |
| Urogen Pharma, INC. | $779.02 | 2022-2025 | |
| Koelis INC. | $593.97 | 2023-2025 | |
| Janssen Scientific Affairs, LLC | $369.23 | 2022-2025 | Erleada |
| Progenics Pharmaceuticals, INC. | $176.70 | 2023-2025 | Pylarify |
| Rochester Medical Corporation | $134.70 | 2022 | |
| Janssen Biotech, INC. | $124.31 | 2025 | Carvykti, Rybrevant |
| Astellas Pharma US INC | $114.89 | 2025 | Padcev |
| Astrazeneca Pharmaceuticals LP | $104.67 | 2023 | Lynparza |
| Janssen Research & Development, LLC | $100.00 | 2022 | |
| Laborie Medical Technologies Corp. | $89.57 | 2020 | |
| Angiodynamics, INC. | $81.95 | 2023 | Nanoknife |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dentsply Ih Ab | $73.84 | 2025 | Lofric |
| Baxter Healthcare | $67.50 | 2025 | Floseal |
| Tempus Ai, INC | $29.54 | 2025 | Xt Cdx |
| Becton, Dickinson and Company | $15.69 | 2023 | Bard Urinary Drainage Bag |
| Ambu INC. | $13.50 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Ahdoot listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.